Prof. Daowen Wang: Pioneer of the 'China Protocol' for Fulminant Myocarditis & Advanced Heart Failure

1. Clinical Leadership & Global Impact: Architect of the "China Protocol"

Professor Daowen Wang is internationally acclaimed as one of the world's foremost authorities on acute, life-threatening cardiovascular conditions. Serving at Tongji Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology (HUST), Professor Wang has fundamentally reshaped the global understanding and emergency management of fulminant myocarditis (FM)—a catastrophic cardiac inflammation characterized by rapid cardiogenic shock, lethal ventricular arrhythmias, and multi-organ failure.

Historically considered one of cardiology's deadliest emergencies with international mortality rates exceeding 50% to 70%, fulminant myocarditis was transformed under Professor Wang’s leadership. By spearheading a systemic, life-support-based comprehensive regimen known worldwide as the "China Protocol," Professor Wang and his team at Tongji Hospital reduced patient in-hospital mortality to an unprecedented level of below 5%.

2. The "China Protocol": Core Principles of Life-Support-Centered Therapy

Rather than relying solely on traditional inotropes and vasopressors—which often exhaust dying cardiomyocytes—the revolutionary therapeutic framework devised by Professor Wang focuses on offloading the struggling myocardium while halting inflammatory destruction:

• Mechanical Circulatory Support First: Early initiation of veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) and Intra-Aortic Balloon Counterpulsation (IABP) to immediately stabilize hemodynamic collapse and rest the myocardium before irreversible metabolic shock occurs.
• Targeted Immunomodulation: Rapid administration of high-dose intravenous immunoglobulin (IVIG) and customized glucocorticoids to rapidly extinguish the fulminant cytokine storm and autoimmune myocardial damage.
• Comprehensive Organ Protection: Protocolized continuous renal replacement therapy (CRRT) and lung-protective ventilation preventing secondary multi-organ cascade failure.
• Myocardial Rest Strategy: Reducing toxic cardiac workloads until endogenous myocardial cellular regeneration and functional recovery take place.

3. Primary Clinical Focus & Conditions Treated

Professor Daowen Wang and his tertiary cardiovascular critical care team provide specialized diagnostics and interventions for patients presenting with severe, unstable, or refractory cardiac pathologies:

• Adult Fulminant Myocarditis (FM): Hyperacute viral or immune checkpoint inhibitor-induced myocarditis presenting with hemodynamic instability or sudden cardiac arrest.
• Cardiogenic Shock & Severe Acute Heart Failure: Comprehensive mechanical circulatory management for acute decompensation secondary to ischemic heart disease or severe cardiomyopathy.
• Complex Arrhythmias & Myocardial Channelopathies: Malignant ventricular tachycardia, ventricular fibrillation storms, and sudden cardiac death risk stratification.
• Refractory Hypertension & Vascular Remodeling: Difficult-to-control secondary hypertension, endocrine-driven cardiovascular disease, and complex vascular pathologies.

4. Landmark Scientific Research & High-Impact Publications

Professor Wang seamlessly combines intensive clinical rescue with deep mechanistic translational research, supported by the National Natural Science Foundation of China (NSFC):

• 2026 European Heart Journal (EHJ): Mitochondrial Disruption Mechanisms in Myocardial Inflammation: This groundbreaking study uncovered how soluble suppression of tumorigenicity 2 (sST2) mediates profound mitochondrial respiratory chain dysfunction in cardiac myocytes during acute myocarditis, identifying novel therapeutic targets to halt intracellular metabolic collapse.
• 2025 Signal Transduction and Targeted Therapy (STTT): Molecular Efficacy of High-Dose Immunoglobulin: Delineated the exact immunoregulatory signaling pathways through which IVIG neutralizes circulating pathogenic autoantibodies and downregulates pro-inflammatory macrophage infiltration in acute myocardial tissue.
• National Guidelines Leadership: As lead author of the Chinese Guidelines for Diagnosis and Treatment of Adult Fulminant Myocarditis (2024 Edition), Professor Wang standardized diagnostic criteria, biomarker thresholds, and stepped mechanical circulatory protocols, training thousands of intensive care cardiologists nationwide.

5. Benchmark Clinical Case Profiles

Professor Wang’s clinical unit has executed numerous complex emergency rescues that serve as national case studies:

• Case Scenario 1 (Hyperacute Cardiogenic Shock Salvage): A young adult patient presented in full cardiogenic shock with left ventricular ejection fraction (LVEF) falling below 15% and recurrent ventricular fibrillation storms. Professor Wang’s unit initiated emergency bedside VA-ECMO and IABP within 40 minutes, coupled with targeted immunomodulation. By day 7, myocardial contractility fully rebounded, enabling successful decannulation with zero permanent neurological or organ deficit.
• Case Scenario 2 (Immune Checkpoint Inhibitor-Induced Myocarditis): A cancer patient undergoing combination immunotherapy developed high-grade conduction block and diffuse acute myocardial necrosis. Under Professor Wang's precision protocol, customized immunosuppression and temporary hemodynamic pacing reversed myocardial stunning, preserving both cardiac function and subsequent oncologic options.

6. Accessing Professor Daowen Wang for International Patients

For international patients, expatriates, and medical centers seeking expert clinical review, urgent second opinions, or intensive cardiovascular management, accessing Professor Wang's specialized unit requires precise medical coordination:

1. Emergency & Subacute Record Assembly: Serial echocardiography reports (with LVEF and wall motion data), cardiac biomarker trends (high-sensitivity Troponin I/T, NT-proBNP, CK-MB), 12-lead ECG strips, coronary angiograms, and cardiac MRI (CMR) imaging if available.
2. Urgent Clinical Pre-Screening: Rapid assessment of clinical stability, transfer eligibility, and indication for remote record consultation versus direct ICU transfer coordination.
3. Physician Authorization & Expert Evaluation: Authorized submission of clinical documents to Professor Wang’s specialized cardiology panel for individualized diagnostic verification and therapeutic roadmap drafting.
4. Comprehensive Inpatient & Concierge Support: For patients requiring admission to Tongji Hospital, coordinated ground transport, bilingual medical liaison, intensive care bed reservation, and multi-specialty follow-up coordination.

7. Inquire & Request a Clinical Assessment

China Medical Concierge - Shanghai (CMCS) is an independent health management and medical concierge service. We connect international patients and expatriates with leading specialists and premier national academic medical centers across China.

To inquire about case evaluations, second opinions, or coordination with Professor Daowen Wang’s cardiology team, please reach out directly through our official channels: